Silexion Therapeutics Corp - Ordinary Shares (SLXN) earnings
Quarterly and annual SLXN reports and results, each read against the price at its own news timestamp. Back to the SLXN overview →
10 measured SLXN earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Silexion Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -0.43% | +0.29% | |
| Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | -0.43% | +0.29% | |
| Form 10-K/A Silexion Therapeutics For: Dec 31 | SEC filing · Form 10-K | -4.21% | -12.57% | |
| Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -1.44% | -3.77% | |
| Form 10-Q Silexion Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.44% | -3.77% | |
| Form 10-K Silexion Therapeutics For: Dec 31 | SEC filing · Form 10-K | — | -3.17% | |
| Form 10-Q Silexion Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +1.07% | +4.30% | |
| Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +1.07% | +4.30% | |
| Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +0.46% | — | |
| Silexion Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | -2.08% | -1.00% |
Keep exploring
More SLXN: analyst actions → · SEC filings → · SLXN overview →